Trial Details
COMPLETEDBasic Information
| Clinical ID | c497 |
|---|---|
| Identifier | NCT06528665 |
| Trial Title | Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Multiple Sclerosis|Ulcerative Colitis |
| Interventions | DRUG: ZEPOSIA® indicated for the treatment of: Relapsing forms of multiple sclerosis, and active ulcerative colitis in adults |
Participant Information
| Sponsor | Corium Innovations, Inc. |
|---|---|
| City | Selangor |
| Country/Region | Malaysia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2025-02-10 |
|---|---|
| Primary Completion Date | 2025-03-16 |
| Completion Date | 2025-04-16 |